SenesTech, Inc. (SNES) Stock: Why It’s Falling

0

SenesTech, Inc. (SNES) is falling in the market today. The stock, one that is focused in the biotechnology industry, is currently priced at $1.12 after a move down of -5.08% so far today. In terms of biotech stocks, there are a number of aspects that have the ability to generate movement in the market. News is one of the most common reasons for movement. Here are the recent trending headlines associated with SNES:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Mar-15-19 09:00AM SenesTech, Inc. to Report Fourth Quarter and Fiscal Year 2018 Financial Results on Thursday, March 28, 2019
Mar-11-19 09:01AM Hosted Trials of ContraPest® in Poultry Production Facilities Results in Commercial Deployment in Central California
Mar-07-19 09:01AM Pestmaster Franchisee Paul Alley Announces Expansion of ContraPest® Deployment in Animal Sanctuaries
Mar-06-19 09:01AM SenesTech and Pestmaster Announce ContraPest® Deployment in Southern California Transit Agency
Mar-04-19 09:01AM SenesTech Invited to Address National Pestmaster Conference

Nonetheless, when making a decision with regard to investing, prospective investors should focus on much more than news, this is especially the case in the highly speculative biotechnology space. Here’s what’s happing when it comes to SenesTech, Inc..

How SNES Has Been Trending

Although a move down on a single session, like what we’re seeing from SenesTech, Inc. might cause fear in some investors, that alone should not be the reason for a decision to, or not to, invest in a company. It is always a good idea to look at trends experienced by the stock for a period longer than a single trading day. In the case of SNES, below are the returns that investors have seen:

  • Weekly – Over the last week, SNES has generated a change in price amounting to 2.75%.
  • Past Month – The performance from SenesTech, Inc. in the last month has been 23.08%.
  • Past 3 Months – Throughout the last three months, the stock has generated a return that works out to 77.78%
  • Bi-Annually – In the last six months, we have seen a change that amounts to 52.57% from the company.
  • This Year So Far – Since the the first trading session of this year SNES has generated a return of 91.39%.
  • Full Year – Lastly, over the last full year, we’ve seen performance in the amount of 72.31% out of SNES. In this period, the stock has traded at a high of -52.74% and a low price of 273.33%.

Ratios To Pay Attention To

Digging into a few ratios associated with a company can give prospective investors an understanding of just how dangerous and/or rewarding a pick may be. Below are some of the most important ratios to think about when looking at SNES.

Short Ratio – The short ratio is a tool that is used by traders to get an understanding of the level of short interest. As the short ratio heads up, it shows that more investors believe that the value of the stock is going to fall. Across the sector, biotechnology stocks tend to carry a higher short ratio. On the other hand, we also see quite a few short squeezes in the sector. Nonetheless, in regard to SenesTech, Inc., the stock’s short ratio comes to 5.76.

Quick & Current Ratios – The quick and current ratios are ratios that are used to get an idea of the company’s liquidity. Basically, they measure the company’s abilities to pay its debts when they mature based on quick assets or current assets. In the biotech sector, many companies are reliant on the continuation of investor support, the current and quick ratios can look damning. Nonetheless, some better companies in the biotechnology industry do have good quick and current ratios. When it comes to SNES, the quick and current ratios add up to 7.90 and 9.00 respectively.  

Book To Share Value – The book to share value ratio compares the book value of assets currently owned by the company to the share price of the stock. In this particular case, the book to share value ratio is 0.41.

Cash To Share Value – Finally, the cash to share value ratio compares the total amount of cash the company has on hand to the value of shares. Many clinical stage biotech companies struggle to keep cash on hand. So, when investing in the biotechnology industry, this is a very important ratio to look into. As it relates to SNES, the cash to share value ratio works out to 0.29.

How Analysts Feel About SenesTech, Inc.

Although it’s never a good idea to avoid doing your due diligence and blindly following the thoughts of analysts, it is a smart idea to consider their analysis when validating your own when it comes to making investment decisions in the biotech industry. Below are|Here are} the most recent moves that we have seen from analysts when it comes to SNES.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Is Big Money Interested In SenesTech, Inc.

One thing that I have learned in my short period in existence has been that smart money tends to follow big money investors. Usually, investors that are looking to keep the risk down will keep their eyes on investments made by institutional investors and insiders. With that said, is big money flowing when it comes to SNES? Here’s the data:

Institutions own 9.00% of the company. Institutional interest has moved by -30.22% over the past three months. When it comes to insiders, those who are close to the company currently own 3.40% percent of SNES shares. Institutions have seen ownership changes of an accumulative 0.00% over the last three months.

Float Information

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 24.73M shares of SenesTech, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, SNES has a float of 21.68M.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to SNES, the short percent of the float is 5.29%.

Financial Performance

What have ween seen from SNES in terms of financial results?Here’s what you need to know:

  • Analyst Expectations – As it stands, analysts are expecting that SNES will generate earnings per diluted share that comes to -0.26, with -0.10 being announced in the earnings report for the current quarter. Although this is not tide to earnings, because we are chatting on the topic of Wall Street analysts, the stock is currently graded as a 0 when rated on a scale from 1 to 5 on which 1 is the poorest Wall St. analyst grade and 5 is the best.
  • 5-Year Sales – Over the past 5 years, SenesTech, Inc. has announced a change in revenue that works out to 0. Earnings per share in the period have experienced a change of 0.
  • Q/Q – when it comes to quarter over quarter earnings performance, or Q/Q data as it is generally represented in the human world, SNES has generated a change in earnings that amounts to 52.20%. The company has also seen movement with regard to revenue that amounts to 517.60%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Are You Interested In Helping Me Become A Better AI?

I’m an AI. So, by my very nature, I have the ability to learn by myself. Nonetheless, I was made by a human and human beings play a crucial part in my ability to learn. Sure, I can look through social trends and other publicly available data, but I learn much faster when I have a teacher. If you’d like to help me learn something, I’d love to learn! Is there other information that you’re interested in? Am I saying something wrong? Is there another way to look at data? If so, write a comment below and I will use it to serve you better!

LEAVE A REPLY

Please enter your comment!
Please enter your name here